• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿茶酚-O-甲基转移酶与乳腺癌风险

Catechol-O-methyltransferase and breast cancer risk.

作者信息

Millikan R C, Pittman G S, Tse C K, Duell E, Newman B, Savitz D, Moorman P G, Boissy R J, Bell D A

机构信息

Department of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill 27599-7400, USA.

出版信息

Carcinogenesis. 1998 Nov;19(11):1943-7. doi: 10.1093/carcin/19.11.1943.

DOI:10.1093/carcin/19.11.1943
PMID:9855007
Abstract

Recent studies suggest that a polymorphism in catechol-O-methyltransferase (COMT) is associated with increased risk of breast cancer. Methylation by COMT is the principal pathway for inactivation of catechol estrogens, which are hypothesized to participate in estrogen-induced carcinogenesis. We examined the association of COMT genotype and breast cancer risk in a population-based, case-control study of invasive breast cancer in North Carolina. The study population consisted of 654 cases and 642 controls, with approximately equal numbers of African-American and white women and women under the age of 50 and aged 50 or over. Contrary to previous reports, we did not observe an association between one or more copies of the low activity COMT allele (COMT-L) and breast cancer risk. Multivariate relative risks (RRs) were 0.8 (95% confidence interval: 0.6-1.1) for COMT-HL and 0.8 (0.6-1.1) for COMT-LL, compared with the COMT-HH genotype. RRs for COMT did not differ among African-American and white women and we did not observe strong modification of RR estimates by menopausal status, body mass index, physical activity or other covariates. Our results suggest that COMT genotype is not related to breast cancer risk.

摘要

近期研究表明,儿茶酚-O-甲基转移酶(COMT)基因多态性与乳腺癌风险增加相关。COMT介导的甲基化是儿茶酚雌激素失活的主要途径,据推测儿茶酚雌激素参与雌激素诱导的致癌过程。我们在北卡罗来纳州一项基于人群的浸润性乳腺癌病例对照研究中,检测了COMT基因型与乳腺癌风险之间的关联。研究人群包括654例病例和642例对照,非裔美国女性和白人女性、50岁以下女性和50岁及以上女性数量大致相等。与之前的报道相反,我们未观察到低活性COMT等位基因(COMT-L)的一个或多个拷贝与乳腺癌风险之间存在关联。与COMT-HH基因型相比,COMT-HL的多变量相对风险(RR)为0.8(95%置信区间:0.6-1.1),COMT-LL为0.8(0.6-1.1)。非裔美国女性和白人女性中COMT的RR无差异,并且我们未观察到绝经状态、体重指数、身体活动或其他协变量对RR估计值有显著影响。我们的结果表明,COMT基因型与乳腺癌风险无关。

相似文献

1
Catechol-O-methyltransferase and breast cancer risk.儿茶酚-O-甲基转移酶与乳腺癌风险
Carcinogenesis. 1998 Nov;19(11):1943-7. doi: 10.1093/carcin/19.11.1943.
2
An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.儿茶酚-O-甲基转移酶低活性变异体的编码等位基因与乳腺癌风险之间的关联。
Cancer Res. 1997 Dec 15;57(24):5493-7.
3
COMT genotype, micronutrients in the folate metabolic pathway and breast cancer risk.儿茶酚-O-甲基转移酶基因分型、叶酸代谢途径中的微量营养素与乳腺癌风险
Carcinogenesis. 2001 Oct;22(10):1661-5. doi: 10.1093/carcin/22.10.1661.
4
Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer.儿茶酚-O-甲基转移酶Val158Met多态性与乳腺癌的关系。
Pharmacogenetics. 2001 Jun;11(4):279-86. doi: 10.1097/00008571-200106000-00001.
5
Polymorphic catechol-O-methyltransferase gene, soy isoflavone intake and breast cancer in postmenopausal women: a case-control study.多态性儿茶酚-O-甲基转移酶基因、大豆异黄酮摄入量与绝经后女性乳腺癌:一项病例对照研究。
Chin J Cancer. 2010 Jul;29(7):683-8. doi: 10.5732/cjc.009.10700.
6
Limited association between a catechol-O-methyltransferase (COMT) polymorphism and breast cancer risk in Japan.儿茶酚-O-甲基转移酶(COMT)基因多态性与日本女性乳腺癌风险之间的关联有限。
Int J Clin Oncol. 2001 Feb;6(1):13-8. doi: 10.1007/pl00012073.
7
Polymorphic catechol-O-methyltransferase gene and breast cancer risk.多态性儿茶酚-O-甲基转移酶基因与乳腺癌风险
Cancer Epidemiol Biomarkers Prev. 2001 Jun;10(6):635-40.
8
Polymorphic catechol-O-methyltransferase gene, duration of estrogen exposure, and breast cancer risk: a nested case-control study in Taiwan.多态性儿茶酚-O-甲基转移酶基因、雌激素暴露持续时间与乳腺癌风险:台湾地区一项巢式病例对照研究
Cancer Detect Prev. 2005;29(5):427-32. doi: 10.1016/j.cdp.2005.07.003. Epub 2005 Sep 26.
9
Catechol-O-methyltransferase gene polymorphism and post-menopausal breast cancer risk.儿茶酚-O-甲基转移酶基因多态性与绝经后乳腺癌风险
Carcinogenesis. 2003 Apr;24(4):681-7. doi: 10.1093/carcin/bgg022.
10
Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population.细胞色素P450 CYP1B1和儿茶酚-O-甲基转移酶(COMT)基因多态性与土耳其人群乳腺癌易感性
Arch Toxicol. 2002 Nov;76(11):643-9. doi: 10.1007/s00204-002-0387-x. Epub 2002 Aug 21.

引用本文的文献

1
Exploration of plasma adiponectin, leptin, and genotype on blood pressure among women who are post-menopause.绝经后女性血浆脂联素、瘦素及基因型与血压关系的研究
J Nutr Sci. 2023 Sep 19;12:e100. doi: 10.1017/jns.2023.75. eCollection 2023.
2
Cancer Biology and Prevention in Diabetes.糖尿病中的癌症生物学与预防
Cells. 2020 Jun 2;9(6):1380. doi: 10.3390/cells9061380.
3
Meta-analysis of genetic polymorphisms in xenobiotic metabolizing enzymes and their association with breast cancer risk.外源性物质代谢酶基因多态性及其与乳腺癌风险关联的Meta分析。
J Genet. 2018 Jun;97(2):523-537.
4
Association between the COMT Val158Met polymorphism and risk of cancer: evidence from 99 case-control studies.儿茶酚-O-甲基转移酶(COMT)Val158Met基因多态性与癌症风险的关联:来自99项病例对照研究的证据。
Onco Targets Ther. 2015 Oct 5;8:2791-803. doi: 10.2147/OTT.S90883. eCollection 2015.
5
Catechol--methyltransferase: characteristics, polymorphisms and role in breast cancer.儿茶酚 - 甲基转移酶:特性、多态性及其在乳腺癌中的作用
Drug Discov Today Dis Mech. 2012 Jun 1;9(1-2):e41-e46. doi: 10.1016/j.ddmec.2012.10.002.
6
Association of COMT Val158Met polymorphism and breast cancer risk: an updated meta-analysis.COMT Val158Met 多态性与乳腺癌风险的关联:一项更新的荟萃分析。
Diagn Pathol. 2012 Oct 8;7:136. doi: 10.1186/1746-1596-7-136.
7
Association between the COMT Val158Met polymorphism and breast cancer risk: a meta-analysis of 30,199 cases and 38,922 controls.COMT Val158Met 多态性与乳腺癌风险的关联:30199 例病例和 38922 例对照的荟萃分析。
Mol Biol Rep. 2012 Jun;39(6):6811-23. doi: 10.1007/s11033-012-1506-2.
8
Towards non-surgical therapy for uterine fibroids: catechol-O-methyl transferase inhibitor shrinks uterine fibroid lesions in the Eker rat model.针对子宫肌瘤的非手术治疗:儿茶酚-O-甲基转移酶抑制剂可使 Eker 大鼠模型中的子宫肌瘤病变缩小。
Hum Reprod. 2011 Nov;26(11):3008-18. doi: 10.1093/humrep/der280. Epub 2011 Sep 6.
9
The genome-wide expression profile of 1,2,3,4,6-penta-O-galloyl-β-D-glucose-treated MDA-MB-231 breast cancer cells: molecular target on cancer metabolism.1,2,3,4,6-五没食子酰基-β-D-葡萄糖处理的 MDA-MB-231 乳腺癌细胞的全基因组表达谱:癌症代谢的分子靶点。
Mol Cells. 2011 Aug;32(2):123-32. doi: 10.1007/s10059-011-2254-1. Epub 2011 May 24.
10
Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response.儿茶酚氧位甲基转移酶药物遗传学与选择性 5-羟色胺再摄取抑制剂反应。
Pharmacogenomics J. 2012 Feb;12(1):78-85. doi: 10.1038/tpj.2010.69. Epub 2010 Sep 28.